Contact
Please use this form to send email to PR contact of this press release:
Rhythm Announces Preliminary Data from Phase 2 Study of Setmelanotide for Treatment of Bardet-Biedl Syndrome
TO:
Please use this form to send email to PR contact of this press release:
Rhythm Announces Preliminary Data from Phase 2 Study of Setmelanotide for Treatment of Bardet-Biedl Syndrome
TO: